ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

ClinicalTrials.gov ID: NCT03595553

Public ClinicalTrials.gov record NCT03595553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Active Controlled Study to Compare the Efficacy and Safety of Ridinilazole (200 mg, Bid) for 10 Days With Vancomycin (125 mg, Qid) for 10 Days in the Treatment of Clostridium Difficile Infection (CDI)

Study identification

NCT ID
NCT03595553
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Summit Therapeutics
Industry
Enrollment
759 participants

Conditions and interventions

Interventions

  • Ridinilazole Drug
  • Vancomycin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 27, 2019
Primary completion
Nov 16, 2021
Completion
Nov 16, 2021
Last update posted
Mar 2, 2023

2019 – 2021

United States locations

U.S. sites
49
U.S. states
22
U.S. cities
48
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35233
GI Alliance - Arizona Digestive Health - Sun City Sun City Arizona 85351
David Geffen School of Medicine at UCLA Los Angeles California 90095
Facey Medical Foundation Mission Hills California 91345
Paradigm Clinical Research Centers, Inc Redding California 96601
University Of California Davis Sacramento California 95817
Midway Immunology and Research Center Ft. Pierce Florida 34982
Alliance Medical Research LLC Lighthouse PT Florida 33064
Phoenix Medical Research LLC Miami Florida 33165
San Marcus Research Miami Lakes Florida 33014
Gasteroenterology Group of Naples Naples Florida 31402
HeuerMD Research Inc Orlando Florida 32819
Pines Care Research Center Inc. Pembroke Pines Florida 33026
Bardmoor Gastroenterology Seminole Florida 33777
Professional Health Care of Pinellas St. Petersburg Florida 33713
Florida Medical Clinic P.A. Zephyrhills Florida 33542
Infectious Disease Specialists of Atlanta Decatur Georgia 30333
Grand Teton Research Group PLLC Idaho Falls Idaho 83404
GI Alliance - Illinois Gastro Group - Glenview Glenview Illinois 60026
Loyola University Medical Center Maywood Illinois 60153
UnityPoint Health Peoria/Proctor Peoria Illinois 61603
Southern Illinois University School of Medicine Springfield Illinois 62702
Carle Foundation Hospital Urbana Illinois 61801
The University of Kansas Medical Center Kansas City Kansas 66160
Ochsner Clinic Foundation New Orleans Louisiana 70121
University of Maryland School of Medicine Baltimore Maryland 21201
St. Vincent Hospital Worcester Massachusetts 01608-1216
Harper Hospital Department of Pharmacy Services Detroit Michigan 48201-2020
Detroit Receiving Hospital Department of Pharmacy Services Detroit Michigan 48201
Aa Mrc Llc Flint Michigan 48504-4730
William Beaumont Hospital Royal Oak Michigan 48073-6712
Revival Research Institute, LLC. Southfield Michigan 48034
Mercury Street Medical Group PLLC Butte Montana 59701
AB Clinical Trials Las Vegas Nevada 89119
New York Presbyterian Hospital Weill Cornell New York New York 10021
James J. Peters VAMC The Bronx New York 10468
ECU Adult Specialty Care Greenville North Carolina 27834
PMG Research of Winston-Salem Winston-Salem North Carolina 27103
St. Vincent Mercy Medical Center Toledo Ohio 43608
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Monument Health Clinical Research Rapid City South Dakota 57701
Chattanooga Research and Medicine CHARM Chattanooga Tennessee 37404-3230
GI Alliance - Texas Digestive Disease Consultants - Arlington Arlington Texas 76012
GI Alliance - Texas Digestive Disease Consultants - Cedar Park Cedar Park Texas 78613
DM Clinical Research (Conroe Regional Hospital) Conroe Texas 77304
FMC Science Lampasas Texas 76550
GI Alliance - Texas Digestive Disease Consultants - San Marcos San Marcos Texas 78666
GI Alliance - Texas Digestive Disease Consultants - Webster Webster Texas 77598
Infectious Diseases Associates of Central VA Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03595553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2023 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03595553 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →